KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 128 filers reported holding KURA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $981,000 | -39.3% | 71,810 | -18.6% | 0.15% | +3.5% |
Q2 2022 | $1,617,000 | +14.2% | 88,217 | +0.2% | 0.14% | +17.2% |
Q1 2022 | $1,416,000 | +380.0% | 88,067 | +318.2% | 0.12% | +454.5% |
Q4 2021 | $295,000 | +59.5% | 21,060 | +85.8% | 0.02% | +69.2% |
Q2 2020 | $185,000 | -65.8% | 11,334 | -79.2% | 0.01% | -69.8% |
Q1 2020 | $541,000 | -9.7% | 54,401 | +24.9% | 0.04% | +16.2% |
Q4 2019 | $599,000 | +47.2% | 43,565 | +62.3% | 0.04% | +54.2% |
Q3 2019 | $407,000 | -1.5% | 26,841 | +27.8% | 0.02% | 0.0% |
Q2 2019 | $413,000 | – | 21,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |